Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

‘Tongue worm’ confirmed in imported dog
L serrata, also known as tongue worm, is rare in Europe, but endemic in parts of the Middle East. (Stock photo)
Young dog brought to the UK from Romanian rescue charity

Vets have confirmed a case of Linguatula serrata in a dog imported from a rescue charity in Romania.

One-year-old crossbreed Donna was presented to a practice in February 2017 with a one-week history of coughing, lethargy and inappetence, and a one-day history of vomiting and haemorrhagic diarrhoea. Signs began a week after she was imported from a Romanian rescue centre that was in the midst of a kennel cough outbreak.

Vet Marianne Thomas, of Dog First Aid, reported the case in Vet Record letters this week (27 January, Vol 182 No 4).

Initial treatment involved broad spectrum antibiotics and probiotics for haemorrhagic gastroenteritis and an upper respiratory tract infection. The patient appeared to make a good recovery but the cough and ocular discharge returned three weeks after the first visit. Imidacloprid/moxidectin and a low dose of symptomatic meloxicam were administered to keep her comfortable and cover any parasitic risk.

Twenty-four to 48 hours after treatment, the dog coughed up a dead worm, which was later confirmed as L serrata. A second dead worm was coughed up a week later.

Endoscopy found no adult worms in the airways, a nasal swab showed no L serrata eggs and monthly faecal samples for six months returned negative results. The patient was declared free from L serrata in October 2017.

L serrata, also known as tongue worm, is rare in Europe, but endemic in parts of the Middle East. Studies have shown a prevalence of 60-70 per cent in stray dogs in parts of Iran. Several cases have so far been reported in dogs imported from Romania. The worm is zoonotic, but few cases have been reported in people in Europe.

Clinical signs in dogs include: purulent nasal discharge, epistaxis, sneezing, coughing, lethargy, dyspnoea due to obstruction (very rare) and an increase upper respiratory noise. According to Dr Thomas, described treatments include nasal flushing with warm saline for diagnosis and possible detachment; surgical removal (but this can cause significant tissue damage and may be impossible if worms are in the sinuses); milbemycin oxide; or macrocyclic lactones.

Dr Thomas concluded: ‘It is recommended dogs from high risk areas be closely monitored for signs. Screening of dogs with relevant clinical signs would be prudent. Prophylactic treatment with a suitable anthelmintic before travel from the country of origin may also be beneficial.’

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.